Paul J. Clancy, EVP, Chief Financial Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 12,158 shares at $116.31 ($1.4M) on 2018-02-08, disclosed to the SEC on 2018-02-08.
Open-market sale of $1.4M ALXN by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.31 | 6,079 | $707K | 50.0% |
| 2 | $116.31 | 6,079 | $707K | 50.0% |
| Total | $116.31 avg | 12,158 | $1.4M | 100% |
| Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |
| BIIB | SELL | 2013-09-19 | $6.6M | — | Filing → |